Cis-4,5-didehydro-13,14-didehydro-11-deoxy-17-phenyl-18,19,20-trinon-PGE, compounds

ABSTRACT

This invention comprises certain analogs of the prostaglandins in which the double bond between C-13 and C-14 is replaced by a triple bond. Also provided in this invention, are novel chemical processes and novel chemical intermediates useful in the preparation of the above prostaglandin analogs. These prostaglandin analogs exhibit prostaglandin-like activity, and are accordingly useful for the same pharmacological purposes as the prostaglandins. Among these purposes are blood pressure lowering, labor induction at term, reproductive-cycle regulation, gastric antisecretory action, and the like.

The present application is a divisional application of ser. No. 657,740, filed Feb. 13, 1976, now pending issuance as a United States patent.

The present invention relates to prostaglandin analogs, for which the essential material constituting disclosure therefor is incorporated by reference here from Ser. No. 820,974, filed Aug. 1, 1977, now U.S. Pat. No. 4,099,015, issued July 4, 1978, which is a divisional application of Ser. No. 657,740. 

I claim:
 1. A prostaglandin analog of the formula ##STR1## wherein Z₄ is cis--CH₂ --CH═CH--(CH₂)_(g) --CH₂ --, wherein g is one, 2, or 3;Wherein R₇ is ##STR2## WHEREIN Z₃ is oxa or methylene, s is zero, one, 2, or 3, and T is chloro, fluoro, trifluoromethyl, alkyl of one to 3 carbon atoms, inclusive, or alkoxy of one to 3 carbon atoms, inclusive, the various T's being the same or different, with the proviso that not more than two T's are other than alkyl; Wherein L₁ is ##STR3## or a mixture of ##STR4## wherein R₃ and R₄ are hydrogen, methyl, or fluoro, being the same or different with the proviso that one of R₃ and R₄ is methyl only when the other is hydrogen or methyl, with the further proviso that one or both of R₃ and R₄ is fluoro only when Z₃ is methylene; Wherein M₁ is ##STR5## wherein R₅ and R₆ are hydrogen or methyl, with the proviso that one of R₅ and R₆ is methyl only when the other is hydrogen; and Wherein R₁ is hydrogen, alkyl of one to 12 carbon atoms, inclusive, cycloalkyl of 3 to 10 carbon atoms, inclusive, aralkyl of 7 to 12 carbon atoms, inclusive, phenyl, phenyl substituted with one, two, or three chloro or alkyl of one to 3 carbon atoms, inclusive, or a pharmacologically acceptable cation.
 2. A compound according to claim 1, wherein ##STR6##
 3. A compound according to claim 2, wherein M₁ is ##STR7##
 4. A compound according to claim 3, wherein g is one.
 5. A compound according to claim 4, wherein R₃, R₄, R₅, and R₆ are all hydrogen.
 6. 15-epi-cis-4,5-Dihehydro-13,14-didehydro-8β,12α-11-deoxy-17-phenyl-18,19,20-trinor-PGE.sub.1, methyl ester, a compound according to claim
 4. 7. A compound according to claim 2, wherein M₁ is ##STR8##
 8. A compound according to claim 7, wherein g is three.
 9. A compound according to claim 7, wherein g is one.
 10. A compund according to claim 9, wherein R₃ and R₄ are both hydrogen.
 11. A compound according to claim 10, wherein R₅ is methyl.
 12. cis-4,5-Didehydro-15-methyl-13,14-didehydro-8β,12.alpha.-11-deoxy-17-phenyl-18,19,20-trinor-PGE₁, a compound according to claim
 11. 13. cis-4,5-Didehydro-15-methyl-13,14-didehydro-8β,12α-11-deoxy-17-phenyl-18,19,20-trinor-PGE₁, a compound according to claim
 11. 14. A compound according to claim 10, wherein R₆ is methyl.
 15. cis-4,5-Didehydro-13,14-didehydro-8β,12α-11-deoxy-17-phenyl-18,19,20-trinor-PGE₁, 15-methyl ether, a compound according to claim
 14. 16. cis-4,5-Didehydro-13,14-didehydro-8β,12α-11-deoxy-17-phenyl-18,19,20-trinor-PGE₁, methyl ether, 15-methyl ether, a compound according to claim
 14. 17. A compound according to claim 10, wherein R₅ and R₆ are both hydrogen.
 18. cis-4,5-Didehydro-13,14-didehydro-8β,12α-11-deoxy-17-phenyl-18,19,20-trinor-PGE₁, a compound according to claim
 17. 19. cis-4,5-Didehydro-13,14-didehydro-8β,12.alpha.-11-deoxy-17-phenyl-18,19,20-trinor-PGE₁, methyl ester, a compound according to claim
 17. 20. A compound according to claim 9, wherein at least one of R₃ and R₄ is methyl.
 21. A compound according to claim 20, wherein R₃ and R₄ are both methyl.
 22. A compound according to claim 21, wherein R₅ is methyl.
 23. cis-4,5-Didehydro-15,16,16-trimethyl-13,14-didehydro-8β,12α-11-deoxy-17-phenyl-18,19,20-trinor-PGE₁, methyl ester, a compound according to claim
 22. 24. A compound according to claim 21, wherein R₆ is methyl.
 25. cis-4,5-Didehydro-16,16-dimethyl-13,14-didehydro-8β,12.alpha.-11-deoxy-17-phenyl-18,19,20-trinor-PGE₁, methyl ester, 15-methyl ether, a compound according to claim
 24. 26. A compound according to claim 21, wherein R₅ and R₆ are both hydrogen.
 27. cis-4,5-Didehydro-13,14-didehydro-8β,12α-11-deoxy-17-phenyl-18,19,20-trinor-PGE₁, a compound according to claim
 26. 28. cis-4,5-Didehydro-13,14-didehydro-8β,12.alpha.-11-deoxy-17-phenyl-18,19,20-trinor-PGE₁, methyl ester, a compound according to claim
 26. 29. A compound according to claim 9, wherein at least one of R₃ and R₄ is fluoro.
 30. A compound according to claim 29, wherein R₃ and R₄ are both fluoro.
 31. A compound according to claim 30, wherein R₅ is methyl.
 32. cis-4,5-Didehydro-15-methyl-16,16-difluoro-13,14-didehydro-8β,12α-11-deoxy-17-phenyl-18,19,20-trinor-PGE₁, methyl ester, a compound according to claim
 31. 33. A compound according to claim 30, wherein R₆ is methyl.
 34. cis-4,5-Didehydro-16,16-difluoro-13,14-didehydro-8β,12.alpha.-11-deoxy-17-phenyl-18,19,20-trinor-PGE₁, methyl ester, 15-methyl ether, a compound according to claim
 33. 35. A compound according to claim 30, wherein R₅ and R₆ are both hydrogen.
 36. cis-4,5-Didehydro-16,16-difluoro-13,14-didehydro-8β,12α-11-deoxy-17-phenyl-18,19,20-trinor-PGE₁, a compound according to claim
 35. 37. cis-4,5-Didehydro-16,16-difluoro-13,14-didehydro-8β,12.alpha.-11-deoxy-17-phenyl-18,19,20-trinor-PGE₁, methyl ester, a compound according to claim
 35. 38. A compound according to claim 1, wherein ##STR9##
 39. A compound according to claim 38, wherein M₁ is ##STR10##
 40. A compound according to claim 39, wherein g is one.
 41. A compound according to claim 40, wherein R₃, R₄, R₅, and R₆ are all hydrogen.
 42. 15-epi-cis-4,5-Didehydro-13,14-didehydro-11-deoxy-17-phenyl-18,19,20-trinor-PGE₁, methyl ester, a compound according to claim
 41. 43. A compound according to claim 38, wherein M₁ is ##STR11##
 44. A compound according to claim 43, wherein g is three.
 45. A compound according to claim 43, wherein g is one.
 46. A compound according to claim 45, wherein R₃ and R₄ are both hydrogen.
 47. A compound according to claim 46, wherein R₅ is methyl.
 48. cis-4,5-Didehydro-15-methyl-13,14-didehydro-11-deoxy-17-phenyl-18,19,20-trinor-PGE₁, a compound according to claim
 47. 49. cis-4,5-Didehyro-15-methyl-13,14-didehydro-11-deoxy-17-phenyl-18,19,20-trinor-PGE₁, methyl ester, a compound according to claim
 47. 50. A compound according to claim 46, wherein R₆ is methyl.
 51. cis-4,5-Didehydro-13,14-didehydro-11-deoxy-17-phenyl-18,19,20-trinor-PGE₁, 15-methyl ether, a compound according to claim
 50. 52. cis-4,5-Didehydro-13,14-didehydro-11-deoxy-17-phenyl-18,19,20-trinor-PGE₁, methyl ester, 15-methyl ether, a compound according to claim
 50. 53. A compound according to claim 46, wherein R₅ and R₆ are both hydrogen.
 54. cis-4,5-Didehydro-13,14-didehydro-11-deoxy-17-phenyl-18,19,20-trinor-PGE₁, a compound according to claim
 53. 55. cis-4,5-Diehydro-13,14-didehydro-11-deoxy-17-phenyl-18,19,20-trinor-PGE₁, methyl ester, a compound according to claim
 53. 56. A compound according to claim 55, wherein at least one of R₃ and R₄ is methyl.
 57. A compound according to claim 56, wherein R₃ and R₄ are both methyl.
 58. A compound according to claim 57, wherein R₅ is methyl.
 59. cis-4,5-Didehydro-15,16,16-trimethyl-13,14-didehydro-11-deoxy-17-phenyl-18,19,20-trinor-PGE₁, methyl ester, a compound according to claim
 58. 60. A compound according to claim 57, wherein R₆ is methyl.
 61. cis-4,5-Didehydro-16,16-dimethyl-13,14-didehydro-11-deoxy-17-phenyl-18,19,20-trinor-PGE₁, methyl ester, 15-methyl ether, a compound according to claim
 60. 62. A compound according to claim 57, wherein R₅ and R₆ are both hydrogen.
 63. cis-4,5-Didehydro-16,16-dimethyl-13,14-didehydro-11-deoxy-17-phenyl-18,19,20-trinor-PGE₁, a compound according to claim
 62. 64. cis-4,5-Didehydro-16,16-dimethyl-13,14-didehydro-11-deoxy-17-phenyl-18,19,20-trinor-PGE₁, methyl ester, a compound according to claim
 62. 65. A compound according to claim 45, wherein at least one of R₃ and R₄ is fluoro.
 66. A compound according to claim 65, wherein R₃ and R₄ are both fluoro.
 67. A compound according to claim 65, wherein R₅ is methyl.
 68. cis-4,5-Didehydro-15-methyl-16,16-difluoro-13,14-didehydro-11-deoxy-17-phenyl-18,19,20-trinor-PGE₁, methyl ester, a compound according to claim
 67. 69. A compound according to claim 66, wherein R₆ is methyl.
 70. cis-4,5-Didehydro-16,16-difluoro-13,14-didehydro-11-deoxy-17-phenyl-18,19,20-trinor-PGE₁, methyl ether, 15-methyl ether, a compound according to claim
 69. 71. A compound according to claim 66, wherein R₅ and R₆ are both hydrogen.
 72. cis-4,5-Didehydro-16,16-difluoro-13,14-didehydro-11-deoxy-17-phenyl-18,19,20-trinor-PGE₁, a compound according to claim
 71. 73. cis-4,5-Didehydro-16,16-difluoro-13,14-didehydro-11-deoxy-17-phenyl-18,19,20-trinor-PGE₁, methyl ester, a compound according to claim
 71. 